Inventor · disambiguated record
Dominique P. Bridon
Also filed as: BRIDON DOMINIQUE · BRIDON DOMINIQUE P
40 granted patents·35 pending applications·2,266 citations·filing 1993–2023
99Inventor score
Files withCONJUCHEM BIOTECHNOLOGIES INC22CONJUCHEM INC21BRIDON DOMINIQUE P8ABBOTT LAB5AXOLTIS PHARMA2
Top patents by PatentIndex Score
75 records- 0198US7256253B2Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood componentsCONJUCHEM BIOTECHNOLOGIES INC·Filed 2005·Granted Aug 14, 2007·105 cites·2 claims
- 0298US6887470B1Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood componentsCONJUCHEM INC·Filed 2000·Granted May 3, 2005·210 cites·9 claims
- 0398US6849714B1Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood componentsCONJUCHEM INC·Filed 2000·Granted Feb 1, 2005·254 cites·13 claims
- 0498US6514500B1Long lasting synthetic glucagon like peptide {GLP-!}CONJUCHEM INC·Filed 2000·Granted Feb 4, 2003·219 cites·2 claims
- 0598US6329336B1Long lasting insulinotropic peptidesCONJUCHEM INC·Filed 2000·Granted Dec 11, 2001·255 cites·14 claims
- 0697US6887849B2Long lasting synthetic glucagon-like peptide {GLP-1}CONJUCHEM INC·Filed 2002·Granted May 3, 2005·126 cites·9 claims
- 0797US6821949B2Long lasting synthetic glucagon-like peptide (GLP-1)CONJUCHEM INC·Filed 2002·Granted Nov 23, 2004·137 cites·4 claims
- 0897US6593295B2Long lasting insulinotropic peptidesCONJUCHEM INC·Filed 2001·Granted Jul 15, 2003·136 cites·29 claims
- 0995US6706892B1Pulmonary delivery for bioconjugationCONJUCHEM INC·Filed 2000·Granted Mar 16, 2004·151 cites·34 claims
- 1095US6500918B2Conjugate comprising an antinociceptive agent covalently bonded to a blood componentCONJUCHEM INC·Filed 2001·Granted Dec 31, 2002·40 cites·16 claims
- 1194US7601691B2Anti-obesity agentsCONJUCHEM BIOTECHNOLOGIES INC·Filed 2005·Granted Oct 13, 2009·27 cites·39 claims
- 1293US7112567B2Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disordersCONJUCHEM INC·Filed 2002·Granted Sep 26, 2006·40 cites·8 claims
- 1393US6610825B2Method for alleviating pain or providing an analgesic effect in a patientCONJUCHEM INC·Filed 2001·Granted Aug 26, 2003·27 cites·22 claims
- 1492US8093206B2Methods involving long lasting synthetic exendin-4 peptide conjugatesBRIDON DOMINIQUE P·Filed 2005·Granted Jan 10, 2012·14 cites·32 claims
- 1592US8084414B2Methods involving long lasting synthetic exendin-4-peptide conjugatesBRIDON DOMINIQUE P·Filed 2005·Granted Dec 27, 2011·14 cites·37 claims
- 1692US8080516B2Long lasting synthetic exendin-4 peptide conjugatesBRIDON DOMINIQUE P·Filed 2005·Granted Dec 20, 2011·14 cites·23 claims
- 1792US8039432B2Method of treatment of diabetes and/or obesity with reduced nausea side effectCONJUCHEM LLC·Filed 2006·Granted Oct 18, 2011·38 cites·28 claims
- 1892US6602981B2Antinociceptive agent derivativeCONJUCHEM INC·Filed 2001·Granted Aug 5, 2003·26 cites·14 claims
- 1990US7737251B2Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disordersCONJUCHEM BIOTECHNOLOGIES INC·Filed 2005·Granted Jun 15, 2010·9 cites·52 claims
- 2090US7307148B2Method for purification of albumin conjugatesCONJUCHEM BIOTECHNOLOGIES INC·Filed 2005·Granted Dec 11, 2007·35 cites·28 claims
- 2189US7741286B2Long lasting anti-angiogenic peptidesCONJUCHEM BIOTECHNOLOGIES INC·Filed 2006·Granted Jun 22, 2010·13 cites·18 claims
- 2288US7090851B1Long lasting fusion peptide inhibitors of viral infectionCONJUCHEM INC·Filed 2000·Granted Aug 15, 2006·29 cites·29 claims
- 2387US7268113B2Long lasting growth hormone releasing factor derivativesCONJUCHEM BIOTECHNOLOGIES INC·Filed 2002·Granted Sep 11, 2007·44 cites·20 claims
- 2487US7144854B1Long lasting anti-angiogenic peptidesCONJUCHEM INC·Filed 2000·Granted Dec 5, 2006·20 cites·11 claims
- 2586US7166695B2Affinity markers for human serum albuminCONJUCHEM BIOTECHNOLOGIES INC·Filed 2004·Granted Jan 23, 2007·19 cites·33 claims
- 2686US6437092B1Conjugates of opioids and endogenous carriersCONJUCHEM INC·Filed 1998·Granted Aug 20, 2002·33 cites·16 claims
- 2784US7582301B1Long-lasting antiviral fusion inhibitor peptide conjugates comprising albumin and human immunodeficiency virus (HIV) peptidesCONJUCHEM BIOTECHNOLOGIES INC·Filed 2000·Granted Sep 1, 2009·21 cites·47 claims
- 2884US6087375AMethods of treating or preventing thrombosesCONJUCHEM INC·Filed 1999·Granted Jul 11, 2000·48 cites·23 claims
- 2982US7741453B2Long lasting fusion peptide inhibitors for HIV infectionCONJUCHEM BIOTECHNOLOGIES INC·Filed 2002·Granted Jun 22, 2010·19 cites·73 claims
- 3076US6440417B1Antibodies to argatroban derivatives and their use in therapeutic and diagnostic treatmentsCONJUCHEM INC·Filed 1999·Granted Aug 27, 2002·49 cites·10 claims
- 3175US5843450AHepatitis GB Virus synthetic peptides and uses thereofABBOTT LAB·Filed 1995·Granted Dec 1, 1998·30 cites·15 claims
- 3273US7608271B2Modified human immunodeficiency virus anti-fusogenic GP41 peptides comprising a maleimide-containing groupCONJUCHEM BIOTECHNOLOGIES INC·Filed 2004·Granted Oct 27, 2009·5 cites·10 claims
- 3369US10501497B2Cyclic polypeptides, method for obtaining them and the therapeutic use thereofAXOLTIS PHARMA·Filed 2016·Granted Dec 10, 2019·1 cites·22 claims
- 3469US7906482B2Anti-obesity agentsADVANCED DIAGNOSTICS AND DISCOVERY·Filed 2007·Granted Mar 15, 2011·1 cites·48 claims
- 3568US2009093408A1Protection of exendin-4 peptides through conjugationBRIDON DOMINIQUE P·Filed 2008·Application pending·0 cites
- 3667US2009175821A1Modified therapeutic peptides with extended half-lives in vivoBRIDON DOMINIQUE P·Filed 2007·Application pending·0 cites
- 3767US2009075890A1Long lasting synthetic exendin-4 peptide conjugates and methods of use thereofCONJUCHEM BIOTECHNOLOGIES INC·Filed 2008·Application pending·0 cites
- 3867US2022378889A1Neo-epitope vaccines and methods of treating cancerEPIVAX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3965US2022362365A1Improved compositions and methods for shared neo-epitope vaccinesEPIVAX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4064US2008146783A1Method for the purification of albumin conjugatesCONJUCHEM BIOTECHNOLOGIES INC·Filed 2007·Application pending·0 cites
- 4163US2009275506A1Long lasting natriuretic peptide derivativesCONJUCHEM BIOTECHNOLOGIES INC·Filed 2008·Application pending·0 cites
- 4263US2025382317A1N-substituted indole derivatives and conjugates for the treatment of cancerEVEXTA BIO·Filed 2023·Application pending·0 cites
- 4363US2009312259A1Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disordersCONJUCHEM BIOTECHNOLOGIES INC·Filed 2009·Application pending·0 cites
- 4462US2008199483A1Long lasting fusion peptide inhibitors of viral infectionCONJUCHEM BIOTECHNOLOGIES INC·Filed 2007·Application pending·0 cites
- 4561US2023293643A1Brk peptides and methods of useCONCARLO HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 4661US2008199532A1Long Lasting Natriuretic Peptide DerivativesCONJUCHEM BIOTECHNOLOGIES INC·Filed 2007·Application pending·0 cites
- 4760US2008176794A1Long lasting fusion peptide inhibitors of viral infectionCONJUCHEM BIOTECHNOLOGIES INC·Filed 2007·Application pending·0 cites
- 4859US5843634AGenetically engineered enzymes and their conjugates for diagnostic assaysABBOTT LAB·Filed 1996·Granted Dec 1, 1998·22 cites·20 claims
- 4959US2021154280A1Neo-epitope vaccines and methods of treating cancerEPIVAX ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 5059US2021145951A1Compositions and methods for shared neo-epitope vaccinesEPIVAX ONCOLOGY INC·Filed 2020·Application pending·0 cites
Showing the top 50 of 75 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →